New app aims to ease cancer anxiety for genetically At-Risk youth
NCT ID NCT06654466
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 31 times
Summary
This study tests a software platform called Nest to see if it helps young adults (ages 18-49) who have a genetic risk for cancer better understand their risks and follow recommended screening. Researchers will compare Nest users to non-users to see if the platform improves knowledge, reduces distress, and increases sharing of risk information with family and doctors. The goal is to improve care and support for people managing hereditary cancer risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL DECISION SUPPORT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.